← Back
Data updated: Mar 10, 2026
PROGENICS PHARMS INC
Oncology
PROGENICS PHARMS INC is a pharmaceutical company focused on Oncology. Key products include PYLARIFY.
2018
Since
2
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...